4//SEC Filing
QUINLAN KEVIN W 4
Accession 0001140361-11-003522
CIK 0000898437other
Filed
Jan 19, 7:00 PM ET
Accepted
Jan 20, 4:05 PM ET
Size
5.7 KB
Accession
0001140361-11-003522
Insider Transaction Report
Form 4
QUINLAN KEVIN W
Chief Financial Officer
Transactions
- Award
Stock Option (Right to Buy)
2011-01-18+30,000→ 30,000 totalExercise: $6.98Exp: 2021-01-18→ Common Stock (30,000 underlying)
Footnotes (1)
- [F1]The stock options vest in four equal installments annually beginning January 18, 2012.
Documents
Issuer
ANIKA THERAPEUTICS INC
CIK 0000898437
Entity typeother
Related Parties
1- filerCIK 0001209114
Filing Metadata
- Form type
- 4
- Filed
- Jan 19, 7:00 PM ET
- Accepted
- Jan 20, 4:05 PM ET
- Size
- 5.7 KB